Form 483

Wyeth Pharmaceutical Division of Wyeth Holdings LLC Form 483, 2026-04-23

FDA issued a Form 483 to Wyeth Pharmaceutical Division of Wyeth Holdings LLC on 2026-04-23 with 1 public-safe observation.

483· Form 483 issuedBiologics1 observation

Wyeth Pharmaceutical Division of Wyeth Holdings LLC · Sanford, United States · Issued April 23, 2026

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Apr 2026
21 CFR 211.56(b)

Written sanitation procedures lacking

Cited by Priscilla M Pastrana, Richard L Bartlett

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.56(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere